Biogen’s Katie King discusses how Biogen is creating digital innovations that address patient access and participation burden, and what the impact of that has been for current trial participants and future patients.
Lead Editorial

Biogen’s Katie King discusses how Biogen is creating digital innovations that address patient access and participation burden, and what the impact of that has been for current trial participants and future patients.